Nilkumhang Suchada, Basit Abdul W
Department of Pharmaceutics, The School of Pharmacy, University of London, 29/39 Brunswick Square, London WC1N 1AX, UK.
Int J Pharm. 2009 Jul 30;377(1-2):135-41. doi: 10.1016/j.ijpharm.2009.03.024. Epub 2009 Apr 1.
A microparticle preparation method based on an emulsion of ethanol in liquid paraffin stabilised using sorbitan sesquioleate which produces enteric microparticles of excellent morphology, size and pH-sensitive drug release was assessed for its robustness to changes in formulation and processing parameters. Prednisolone and methacrylic acid and methyl methacrylate copolymer (Eudragit S) were the drug and polymer of choice. Emulsion solvent evaporation procedures are notoriously sensitive to changes in methodology and so emulsion stirring speed, drug loading, polymer concentration and surfactant (emulsifier) concentration were varied; microparticle size, encapsulation efficiency, yield and in vitro dissolution behaviour were assessed. The yield and encapsulation efficiency remained high under all stirring speeds, drug loadings and polymer concentrations. This suggests that the process is flexible and efficiency can be maintained. Surfactant concentration was an important parameter; above an optimum concentration resulted in poorly formed particles. All processing parameters affected particle size but this did not alter the acid resistance of the microparticles. At high pH values the smaller microparticles had the most rapid drug release. In conclusion, the microparticle preparation method was resistant to many changes in processing, although surfactant concentration was critical. Manipulation of particle size can be used to modify the drug release profiles without adversely affecting the gastro-resistant properties of these pH-responsive microparticles.
评估了一种基于用脱水山梨醇倍半油酸酯稳定的液体石蜡中乙醇乳液的微粒制备方法,该方法可产生形态、尺寸和pH敏感药物释放性能优异的肠溶微粒,考察其对制剂和工艺参数变化的稳健性。泼尼松龙、甲基丙烯酸与甲基丙烯酸甲酯共聚物(尤特奇S)为选用的药物和聚合物。众所周知,乳液溶剂蒸发法对方法的变化很敏感,因此改变了乳液搅拌速度、载药量、聚合物浓度和表面活性剂(乳化剂)浓度;评估了微粒大小、包封效率、产率和体外溶出行为。在所有搅拌速度、载药量和聚合物浓度下,产率和包封效率均保持较高水平。这表明该工艺具有灵活性,可维持效率。表面活性剂浓度是一个重要参数;高于最佳浓度会导致颗粒形成不佳。所有工艺参数均会影响颗粒大小,但这并未改变微粒的耐酸性。在高pH值下,较小的微粒药物释放最快。总之,尽管表面活性剂浓度至关重要,但微粒制备方法对许多工艺变化具有抗性。可通过控制颗粒大小来改变药物释放曲线,而不会对这些pH响应性微粒的抗胃性能产生不利影响。